Abstract
Impact of acetaldehyde and TP53-CHIP on myeloid neoplasm mortality. A, The cause-specific survival from myeloid neoplasms was estimated using the Kaplan–Meier method. Individuals prone to acetaldehyde exposure were defined as individuals with both rs671 Lys+ and ever-drinker status. B, HRs and their 95% CIs were estimated using Cox proportional hazards models of myeloid neoplasm mortality adjusted for age, sex, drinking habits, alcohol consumption, smoking habits, Brinkman index, body mass index, comorbidities (hyperlipidemia, hypertension, diabetes, and cancer), and ALDH2. AcAld, acetaldehyde.